The Latest
The WasteWatcher340B Drug Discount Program is a Nightmare
Like many other well-intended programs 340B has ended up both wasting money and failing to provide benefits for patients.
The WasteWatcherKansas Bankrolls Buc-ee the Beaver
Kansas lawmakers gave tax-free public financing to a powerful private interest.
The WasteWatcherThe Proposed Musk Efficiency Commission Could Save Trillions
Trump saying that trillions of dollars can be saved from a government efficiency commission headed by Musk isn't an exaggeration.
The WasteWatcherPrice Controls Are Always a Bad Idea
Prices controls have always disrupted the marketplace and created shortages or excesses.
The WasteWatcherThe Future of the Universal Service Fund
To save taxpayer dollars, Congress should look at revamping the USF program instead of trying to expanding its contribution base.
The WasteWatcherThe Case for 340B Reform Is Made on Capitol Hill
At a Capitol Hill briefing on the urgent need for reforms to the 340B Drug Pricing Program, the case was made for prompt action to fix the program. The event took place at the Senate Visitors Center on September 23, 2024, and was hosted by the...
Press ReleaseCitizens Against Government Waste Names Rep. Pramila Jayapal September 2024 Porker of the Month
Rep. Jayapal is trying to force taxpayers to pay taxes on unrealized gains on investments.
The WasteWatcherProtecting Intellectual Property in an AI World
Intellectual property rights should be protected when artificial intelligence is used in creative works.
Op-EdsReforming 340B vital for affordable medication for low-income patients
Unfortunately, today, the 340B program is failing those it was meant to serve.
Op-EdsThe Biden-Harris rent control ruse would worsen the housing shortage, raise costs
Proposal to cap rent increases at 5 percent would reduce the stock of available homes.
The WasteWatcherUSPTO-FDA Study Debunks Critics and Demonstrates the Importance of Protecting IP
USPTO-FDA study reinforces the need to protect pharmaceutical intellectual property rights for the future of new drug development.
The WasteWatcherThe IRA Has Undermined Medicare Part D
The Inflation Reduction Act creates instability in the Medicare Part D Program.
